Loading company…
Mexbrain develops therapies that remove excess or toxic metals from the body while maintaining metal balance.
Founded in 2017 and based in Fontaines-Saint-Martin, France, Mexbrain develops therapeutic technologies to eliminate toxic or over-concentrated metals from the body while maintaining metal homeostasis. Its technologies are intended to help healthcare professionals treat conditions including sepsis and neurodegenerative disorders. The company raised Series A funding in May 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in